A hospice nurse is caring for a 78-year-old patient with end-stage pancreatic cancer who is experiencing severe pain despite current medication regimen. The patient's family is concerned about increasing the morphine dose due to fear of addiction. What is the most appropriate nursing intervention?

Understanding the Clinical Scenario

This question addresses a critical and common barrier in end-of-life care: the fear of addiction when using opioids like morphine for severe cancer pain. The patient has end-stage pancreatic cancer and is experiencing severe, uncontrolled pain. The family's concern, while well-intentioned, stems from a misunderstanding of key concepts in palliative care. The priority is to manage the patient's suffering effectively while addressing the family's fears through education.

Analyzing the Options

Option 1 dismisses the family's concerns and proceeds unilaterally. This approach breaks therapeutic communication and trust, which are essential in hospice care. Pain management requires a collaborative approach with the patient and family.


Option 2 suggests abandoning pharmacological management for non-pharmacological methods only. For severe, end-stage cancer pain, the World Health Organization's analgesic ladder indicates that non-opioid and adjuvant therapies are insufficient; strong opioids like morphine are the cornerstone of treatment.


Option 3 prioritizes the family's unfounded fear over the patient's clinical need. Decreasing a morphine dose that is already failing to control severe pain would lead to unnecessary suffering and is a direct violation of the ethical principle of beneficence.


Option 4 is the correct intervention. It directly addresses the core issue—a knowledge deficit regarding the difference between physical dependence and addiction (substance use disorder). In end-of-life care, the ethical and clinical priority is effective pain relief, which often requires escalating doses to match the patient's increasing physiological need.

Deep Dive: Physical Dependence vs. Addiction

The family's fear is rooted in a common misconception. The comprehensive review by Cordero-Pérez et al. [1] clarifies that opioids exert their effects through central and peripheral nociceptive pathways. With regular, long-term use, the body adapts physiologically, leading to physical dependence. This is a normal neurobiological response where abrupt cessation or a rapid dose decrease causes a withdrawal syndrome. It is not a sign of addiction.

Addiction, or substance use disorder, is a complex psychological and behavioral condition characterized by compulsive drug-seeking behavior, loss of control over use, and continued use despite harm. A patient with severe, unrelenting cancer pain who is taking morphine for analgesia is not exhibiting these behaviors; they are seeking relief from suffering. The study by Kweh et al. [2] highlights that inadequate knowledge and negative perceptions among healthcare professionals are significant barriers to effective cancer pain management. This same knowledge gap exists in families and must be addressed with compassionate, evidence-based education.

The Priority of Pain Control in End-of-Life Care

In the context of terminal illness, the ethical framework shifts. The principle of double effect and the overwhelming focus on comfort and dignity make adequate analgesia the paramount goal. The risk of respiratory depression, while a clinical consideration, is managed through careful titration, and tolerance to this effect develops. The risk of true addiction in a patient with no prior history of substance misuse is exceedingly low. The nurse must explain that increasing the morphine dose is a medically necessary response to escalating pain and disease progression, not a sign of addictive behavior. The goal is to allow the patient to spend their final days with dignity, free from pain, and surrounded by family who understand the treatment's purpose.